Multistate Models as a Framework for Estimand Specification in Clinical Trials of Complex Processes

09/27/2022
by   Alexandra Būhler, et al.
0

Intensity-based multistate models provide a useful framework for characterizing disease processes, the introduction of interventions, loss to follow-up, and other complications arising in the conduct of randomized trials studying complex life history processes. Within this framework we discuss the issues involved in the specification of estimands and show the limiting values of common estimators of marginal process features based on cumulative incidence function regression models. When intercurrent events arise we stress the need to carefully define the target estimand and the importance of avoiding targets of inference that are not interpretable in the real world. This has implications for analyses, but also the design of clinical trials where protocols may help in the interpretation of estimands based on marginal features.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
12/19/2020

Revisiting ICH E9 (R1) during the COVID-19 pandemic

The current COVID-19 pandemic poses numerous challenges for ongoing clin...
research
05/22/2023

Some power function distribution processes

It is known that all the proportional reversed hazard (PRH) processes ca...
research
03/08/2021

Generalizing trial evidence to target populations in non-nested designs: Applications to AIDS clinical trials

Comparative effectiveness evidence from randomized trials may not be dir...
research
06/30/2023

Analyzing Generalized Pólya Urn Models using Martingales, with an Application to Viral Evolution

The randomized play-the-winner (RPW) model is a generalized Pólya Urn pr...

Please sign up or login with your details

Forgot password? Click here to reset